Cyteir Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
19 Mar 2024	Form 3: Leonard Braden Michael, 10% owner Holds 3,369,687 shares of Common Stock, par value $0.001 per share
04 May 2022	Form 3: Veness Adam M, General Counsel No securities owned
24 Feb 2022	Form 3: Sands Stephen H., Director No securities owned
07 Feb 2022	Form 3: Thero John F, Director No securities owned
16 Dec 2021	Form 3: Humphrey Jeffrey, Director No securities owned
17 Jun 2021	Form 3: Droia Invest Ii SCSp, 10% owner and 5 others
17 Jun 2021	Form 3: Zakrzewski Joseph S, Director Holds 77,267 shares of Common Stock
17 Jun 2021	Form 3: Novo Holdings A/S, 10% owner
17 Jun 2021	Form 3: Romberger Timothy, Director Holds 290,388 shares of Common Stock
17 Jun 2021	Form 3: Naesens Janwillem, Director
17 Jun 2021	Form 3: Hong Karen, Director No securities owned
17 Jun 2021	Form 3: Bracken Racquel, Director
17 Jun 2021	Form 3: Molineaux Susan, Director
17 Jun 2021	Form 3: George Jean, Director
17 Jun 2021	Form 3: Venrock Associates VII, L.p., 10% owner and 2 others
17 Jun 2021	Form 3: Gaiero David G, Vice President, Finance
17 Jun 2021	Form 3: Secrist John Paul, Chief Scientific Officer
17 Jun 2021	Form 3: Gengos Andrew, Chief Business Officer Holds 73,534 shares of Common Stock
17 Jun 2021	Form 3: Renschler Markus Md, Director Holds 841,954 shares of Common Stock

Comments